4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-056357
EVP, Chief Financial Officer sold 5,108 shares at $22.64 ($115,645)
- EVP, Chief Financial Officer acquired 9,912 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-11-17 | Option exercise | +4,956 | 20,638 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-11-17 | Option exercise | +4,956 | 25,594 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-11-20 | Sale | −5,108 | $22.64 | $115,645 | 20,486 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-11-17 | Option exercise · Restricted Stock Units | −4,956 | 19,826 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-11-17 | Option exercise · Restricted Stock Units | −4,956 | 19,826 | D | ||
| Open-market sales · 5,108 sh · avg $22.64 · $115,645 | |||||||
Loading xslF345X05/doc4.xml…